ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
6,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
7,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
8,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
8,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
10,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
11,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
12,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
13,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
14,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
15,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
16,2,Lung neoplasm,Respiratory tract and pleural neoplasms malignancy unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
16,3,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
17,1,Headache,Headaches NEC,Headaches,Nerv,N
18,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
18,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
18,3,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
